Robert G. L. Shorr
Oprichter bij Cornerstone Pharmaceuticals, Inc.
Actieve functies van Robert G. L. Shorr
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Directeur/Bestuurslid | - | - |
Hoofd Techniek/Wetenschap/O&O | - | - | |
Oprichter | - | - | |
Algemeen Directeur | 01-01-2000 | 10-10-2014 | |
Stony Brook University | Corporate Officer/Principal | 01-01-1998 | - |
Tissue Engineering Charities, Inc. | Directeur/Bestuurslid | 16-05-2011 | - |
Imperial College London | Directeur/Bestuurslid | 01-01-1999 | - |
Loopbaan van Robert G. L. Shorr
Eerdere bekende functies van Robert G. L. Shorr
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BRAINSTORM CELL THERAPEUTICS INC. | Directeur/Bestuurslid | 31-03-2005 | 01-02-2018 |
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Directeur/Bestuurslid | - | 28-04-2005 |
UNITED THERAPEUTICS CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-01-2005 | 01-01-2005 |
Smithkline & French Laboratories US, Inc. | Corporate Officer/Principal | 01-01-1988 | 01-01-1988 |
AT Biochem, Inc. | Hoofd Techniek/Wetenschap/O&O | - | - |
Oprichter | 07-05-2010 | - | |
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Opleiding van Robert G. L. Shorr
University of London | Doctorate Degree |
State University of New York at Buffalo | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 10 |
Verenigd Koninkrijk | 4 |
Operationeel
Director/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 4 |
Founder | 2 |
Sectoraal
Health Technology | 5 |
Consumer Services | 5 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
ENZON PHARMACEUTICALS, INC. | Health Technology |
UNITED THERAPEUTICS CORPORATION | Health Technology |
BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Commercial Services |
Smithkline & French Laboratories US, Inc. | |
AT Biochem, Inc. | |
Tissue Engineering Charities, Inc. |
- Beurs
- Insiders
- Robert G. L. Shorr
- Ervaring